*The table illustrates the results of odds and risk ratios of a 20% increase in plasma cholinesterase activity among patients with RA treated with conventional therapy or conventional + biologic therapy compared to the RA-no therapy group. The gene discussed is BCHE; the disease is rheumatoid arthritis.